Literature DB >> 30407487

Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.

Rhonda Arthur1, Theodore M Brasky2, Tracy E Crane3, Ashley S Felix4, Andrew M Kaunitz5, Aladdin H Shadyab6, Lihong Qi7, Sylvia Wassertheil-Smoller1, Thomas E Rohan1.   

Abstract

Lifestyle-related factors influence risk of endometrial and ovarian cancers, but few studies have examined their joint associations with risk of these cancers. Using multivariable Cox regression models, we assessed the association of a healthy lifestyle index (HLI-a composite score (range, 0-20) involving diet, alcohol consumption, physical activity, body mass index, and smoking; higher scores represent healthier behavior) with risk of endometrial and ovarian cancers among 108,136 postmenopausal women who were recruited in the US Women's Health Initiative study between 1993 and 1998. After a median follow-up of 17.9 years, 1,435 endometrial cancer cases and 904 ovarian cancer cases had been ascertained. Women in the highest quintile of the HLI score had a lower risk of overall, type I, well-differentiated, moderately differentiated, poorly differentiated, and localized endometrial cancer than those in the lowest quintile (for quintile 5 vs. quintile 1, hazard ratio (HR) = 0.61 (95% CI: 0.51, 0.72), HR = 0.60 (95% CI: 0.49, 0.72), HR = 0.66 (95% CI: 0.46, 0.96), HR = 0.69 (95% CI: 0.52, 0.90), HR = 0.49 (95% CI: 0.34, 0.72), and HR = 0.61 (95% CI: 0.50, 0.74), respectively). The HLI score had a weak positive association with risk of serous ovarian cancer. Our findings underscore the potential importance of a healthy lifestyle in lowering endometrial cancer risk among postmenopausal women.

Entities:  

Mesh:

Year:  2019        PMID: 30407487      PMCID: PMC6357793          DOI: 10.1093/aje/kwy249

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  46 in total

1.  Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study.

Authors:  Dora Romaguera; Anne-Claire Vergnaud; Petra H Peeters; Carla H van Gils; Doris S M Chan; Pietro Ferrari; Isabelle Romieu; Mazda Jenab; Nadia Slimani; Françoise Clavel-Chapelon; Guy Fagherazzi; Florence Perquier; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Anne von Rüsten; Anne Tjønneland; Anja Olsen; Christina C Dahm; Kim Overvad; José Ramón Quirós; Carlos A Gonzalez; María José Sánchez; Carmen Navarro; Aurelio Barricarte; Miren Dorronsoro; Kay-Tee Khaw; Nicholas J Wareham; Francesca L Crowe; Timothy J Key; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Giovanna Masala; Paolo Vineis; Rosario Tumino; Sabina Sieri; Salvatore Panico; Anne M May; H Bas Bueno-de-Mesquita; Frederike L Büchner; Elisabet Wirfält; Jonas Manjer; Ingegerd Johansson; Göran Hallmans; Guri Skeie; Kristin Benjaminsen Borch; Christine L Parr; Elio Riboli; Teresa Norat
Journal:  Am J Clin Nutr       Date:  2012-05-16       Impact factor: 7.045

2.  Cigarette smoking and the risk of endometrial cancer: a meta-analysis.

Authors:  Bo Zhou; Li Yang; Qingmin Sun; Rihong Cong; Haijuan Gu; Naping Tang; Huaijun Zhu; Bin Wang
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

3.  Phytoestrogen intake and risk of ovarian cancer: a meta- analysis of 10 observational studies.

Authors:  Xin-Lan Qu; Yuan Fang; Ming Zhang; Yuan-Zhen Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  Veronika Fedirko; Mazda Jenab; Sabina Rinaldi; Carine Biessy; Naomi E Allen; Laure Dossus; N Charlotte Onland-Moret; Madlen Schütze; Anne Tjønneland; Louise Hansen; Kim Overvad; Françoise Clavel-Chapelon; Nathalie Chabbert-Buffet; Rudolf Kaaks; Annekatrin Lukanova; Manuela M Bergmann; Heiner Boeing; Antonia Trichopoulou; Erifili Oustoglou; Antonia Barbitsioti; Calogero Saieva; Giovanna Tagliabue; Rocco Galasso; Rosario Tumino; Carlotta Sacerdote; Petra H Peeters; H Bas Bueno-de-Mesquita; Elisabete Weiderpass; Inger Torhild Gram; Soledad Sanchez; Eric J Duell; Esther Molina-Montes; Larraitz Arriola; Maria-Dolores Chirlaque; Eva Ardanaz; Jonas Manjer; Eva Lundin; Annika Idahl; Kay-Tee Khaw; Dora Romaguera-Bosch; Petra A Wark; Teresa Norat; Isabelle Romieu
Journal:  Ann Epidemiol       Date:  2012-12-25       Impact factor: 3.797

Review 5.  Cancer-related inflammation.

Authors:  Juliana Candido; Thorsten Hagemann
Journal:  J Clin Immunol       Date:  2012-12-09       Impact factor: 8.317

6.  Menopausal hormone therapy and risk of endometrial cancer.

Authors:  Louise A Brinton; Ashley S Felix
Journal:  J Steroid Biochem Mol Biol       Date:  2013-05-13       Impact factor: 4.292

7.  Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective US cohort.

Authors:  Janet S Hildebrand; Susan M Gapstur; Mia M Gaudet; Peter T Campbell; Alpa V Patel
Journal:  Cancer Causes Control       Date:  2015-09-03       Impact factor: 2.506

8.  Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.

Authors:  Catherine M Olsen; Christina M Nagle; David C Whiteman; Roberta Ness; Celeste Leigh Pearce; Malcolm C Pike; Mary Anne Rossing; Kathryn L Terry; Anna H Wu; Harvey A Risch; Herbert Yu; Jennifer A Doherty; Jenny Chang-Claude; Rebecca Hein; Stefan Nickels; Shan Wang-Gohrke; Marc T Goodman; Michael E Carney; Rayna K Matsuno; Galina Lurie; Kirsten Moysich; Susanne K Kjaer; Allan Jensen; Estrid Hogdall; Ellen L Goode; Brooke L Fridley; Robert A Vierkant; Melissa C Larson; Joellen Schildkraut; Cathrine Hoyo; Patricia Moorman; Rachel P Weber; Daniel W Cramer; Allison F Vitonis; Elisa V Bandera; Sara H Olson; Lorna Rodriguez-Rodriguez; Melony King; Louise A Brinton; Hannah Yang; Montserrat Garcia-Closas; Jolanta Lissowska; Hoda Anton-Culver; Argyrios Ziogas; Simon A Gayther; Susan J Ramus; Usha Menon; Aleksandra Gentry-Maharaj; Penelope M Webb
Journal:  Endocr Relat Cancer       Date:  2013-03-22       Impact factor: 5.678

9.  Active and passive cigarette smoking and the risk of endometrial cancer in Poland.

Authors:  Hannah P Yang; Louise A Brinton; Elizabeth A Platz; Jolanta Lissowska; James V Lacey; Mark E Sherman; Beata Peplonska; Montserrat Garcia-Closas
Journal:  Eur J Cancer       Date:  2009-12-28       Impact factor: 9.162

10.  Mediterranean diet and risk of endometrial cancer: a pooled analysis of three Italian case-control studies.

Authors:  M Filomeno; C Bosetti; E Bidoli; F Levi; D Serraino; M Montella; C La Vecchia; A Tavani
Journal:  Br J Cancer       Date:  2015-05-12       Impact factor: 7.640

View more
  9 in total

Review 1.  Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis.

Authors:  Alireza Khodavandi; Fahimeh Alizadeh; Ahmad Faizal Abdull Razis
Journal:  Eur J Nutr       Date:  2020-07-13       Impact factor: 5.614

2.  The global burden and associated factors of ovarian cancer in 1990-2019: findings from the Global Burden of Disease Study 2019.

Authors:  Shiwen Zhang; Chen Cheng; Zejian Lin; Linzi Xiao; Xin Su; Lu Zheng; Yingjun Mu; Minqi Liao; Ruiqing Ouyang; Wanlin Li; Junrong Ma; Jun Cai; Lu Liu; Donghong Wang; Fangfang Zeng; Jun Liu
Journal:  BMC Public Health       Date:  2022-07-30       Impact factor: 4.135

3.  NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness.

Authors:  Nanette F Santoro; Helen L Coons; Samar R El Khoudary; C Neill Epperson; Julianne Holt-Lunstad; Hadine Joffe; Sarah H Lindsey; Kara L Marlatt; Patti Montella; Gloria Richard-Davis; Bonny Rockette-Wagner; Marcel E Salive; Cynthia Stuenkel; Rebecca C Thurston; Nancy Woods; Holly Wyatt
Journal:  Menopause       Date:  2022-05-01       Impact factor: 3.310

4.  Combined Lifestyle Behaviors and the Incidence of Common Cancer Types in the Norwegian Women and Cancer Study (NOWAC).

Authors:  Sairah L F Chen; Tonje Braaten; Kristin B Borch; Pietro Ferrari; Torkjel M Sandanger; Therese H Nøst
Journal:  Clin Epidemiol       Date:  2021-08-16       Impact factor: 4.790

5.  Association Between Diet Quality and Risk of Ovarian and Endometrial Cancers: A Systematic Review of Epidemiological Studies.

Authors:  Yu-Hua Zhang; Zhuo Li; Ming-Zi Tan
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

6.  Prospective Analyses of Lifestyle Factors Related to Energy Balance and Ovarian Cancer Risk by Infiltration of Tumor-Associated Macrophages.

Authors:  Naoko Sasamoto; Tianyi Wang; Mary K Townsend; Jonathan L Hecht; A Heather Eliassen; Mingyang Song; Kathryn L Terry; Shelley S Tworoger; Holly R Harris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-03-02       Impact factor: 4.090

Review 7.  Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.

Authors:  Satoru Kyo; Kentaro Nakayama
Journal:  Int J Mol Sci       Date:  2020-08-23       Impact factor: 5.923

8.  Adherence to Cancer Prevention Guidelines and Endometrial Cancer Risk: Evidence from a Systematic Review and Dose-Response Meta-analysis of Prospective Studies.

Authors:  Hui Sun; Qing Chang; Ya-Shu Liu; Yu-Ting Jiang; Ting-Ting Gong; Xiao-Xin Ma; Yu-Hong Zhao; Qi-Jun Wu
Journal:  Cancer Res Treat       Date:  2020-09-14       Impact factor: 4.679

9.  Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA-1 cohort study.

Authors:  Jan Yvan Verbakel; Ruben Heremans; Laure Wynants; Elisabeth Epstein; Bavo De Cock; Maria Angela Pascual; Francesco Paolo Giuseppe Leone; Povilas Sladkevicius; Juan Luis Alcazar; Catherine Van Pachterbeke; Ligita Jokubkiene; Robert Fruscio; Tom Bourne; Ben Van Calster; Dirk Timmerman; Thierry Van den Bosch
Journal:  Int J Gynaecol Obstet       Date:  2022-02-07       Impact factor: 4.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.